Clinical Trials

Clinical Trials Market Research Reports

Clinical Trials Market Research Reports Analysis and Trends

Clinical trials are research studies that test how well new medical approaches work in people. Each study answers scientific questions and tries to find better ways to prevent, screen for, diagnose or treat a disease. Clinical trials might compare a new treatment to a treatment that is already available.

Every clinical trial has a protocol, or action plan, for conducting the trial. The plan describes what will be done in the study, how it will be conducted, and why each part of the study is necessary. For example, doctors use clinical trials to develop new treatments for serious diseases such as cancer.

Uses of Clinical Trials

Clinical trials are performed to evaluate new drugs, medical devices such as new catheter, biologics, psychological therapies, or other interventions. Clinical trials are done before the national regulatory authority approves marketing of the drug or device, or a new dose of the drug, for use on patients.

Types of clinical trials

During the clinical trial, the investigators: recruit patients with the predetermined characteristics, administer the treatment, and collect data on the patients' health for a defined time period. These patients can be volunteers who are not paid for participating in clinical trials. These data include measurements like vital signs, concentration of the study drug in the blood, and whether the patient's health improves or not. The researchers send the data to the trial sponsor, who then analyzes the pooled data using statistical tests.

Based on researcher’s behaviour, clinical trials can be classified as observational study and interventional study.

In an observational study, the investigators observe the subjects and measure their outcomes. Whereas in an interventional study, the investigators give the research subjects a particular medicine or other intervention and compare the treated subjects to subjects who receive no treatment or standard treatment. Then the researchers measure how the subjects' health changes.

Industry Overview

Since, clinical research is the bridge between the lab and the market for new drugs, the clinical trial industry is constantly evolving, and new clinical studies are being launched at an ever-growing pace.

India's pharmaceutical market is the second largest in Asia, growing by more than 9% annually. The Indian pharmaceutical industry is estimated at US$ 5.40 billion and projected to grow up to US$ 7.40 billion. India is increasingly being recognized as a centre for global clinical trials.   

Clinical Trials Industry Current Trends

According to the reports, the Clinical Trials market worldwide is worth over US$ 45 billion and the industry has employed an estimated 2,10,000 people in the US and over 70,000 people in the UK and they  form one third of the total Research & Development staff.

As per the reports, Clinical Trial industry in India touched US$400 million in 2010, up from US$230 million in 2008 and is expected to touch US$1.09 billion by 2014. The cost of conducting clinical trials in developing countries like India and China is far lower when compared to their developed counterparts.

Major Clinical Trials Industry Players

Some of the major pharmaceutical and clinical research organizations in India are Asian Clinical Trials, Dr Reddy's Lab, Glaxo Smithkline, Igate, Periclinical, Quintiles, Lotus Labs, Ranbaxy Laboratories, Novartis, and Omnicare. 

Publication Single User License (PDF) Price
Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Herpes Infections Global Clinical Trials Review, H2, 2014

Herpes Infections Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Herpes Infections Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Community-Acquired Infections Global Clinical Trials Review, H2, 2014

Community-Acquired Infections Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Community-Acquired Infections Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Histoplasmosis Global Clinical Trials Review, H2, 2014

Histoplasmosis Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Histoplasmosis Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014

Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Complicated Intra-Abdominal Infections Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
HIV-1 Infection Global Clinical Trials Review, H2, 2014

HIV-1 Infection Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

HIV-1 Infection Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2014

Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Gram-Negative Bacterial Infections Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014

Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Gram-Positive Bacterial Infections Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
H1N1 Infection Global Clinical Trials Review, H2, 2014

H1N1 Infection Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

H1N1 Infection Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014

H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014

Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Hemorrhagic Fever Global Clinical Trials Review, H2, 2014

Hemorrhagic Fever Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Hemorrhagic Fever Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Apnea Global Clinical Trials Review, H2, 2014

Apnea Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Apnea Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Hepatitis D Global Clinical Trials Review, H2, 2014

Hepatitis D Global Clinical Trials Review, H2, 2014

Date Published: Nov 30 2014

Hepatitis D Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Erosive Oral Lichen Planus Global Clinical Trials Review, H2, 2014

Erosive Oral Lichen Planus Global Clinical Trials Review, H2, 2014

Date Published: Nov 28 2014

Erosive Oral Lichen Planus Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Chlamydia Infections Global Clinical Trials Review, H2, 2014

Chlamydia Infections Global Clinical Trials Review, H2, 2014

Date Published: Nov 28 2014

Chlamydia Infections Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
AIDS-Related Complex Global Clinical Trials Review, H2, 2014

AIDS-Related Complex Global Clinical Trials Review, H2, 2014

Date Published: Nov 28 2014

AIDS-Related Complex Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014

Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014

Date Published: Nov 28 2014

Bordetella Pertussis Infections Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Botulism Global Clinical Trials Review, H2, 2014

Botulism Global Clinical Trials Review, H2, 2014

Date Published: Nov 28 2014

Botulism Global Clinical Trials Review, H2, 2014

Summary

$2,500.00
Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014

Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014

Date Published: Nov 28 2014

Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014

Summary

$2,500.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data